The METTL3–METTL14 complex mediates expression of tumor-related genes via m6A modification of associated mRNA, thus controlling cancer stem cell pluripotency, tumor initiation, epithelial-mesenchymal transformation (EMT), angiogenesis, and the DNA-damage response. The gene discussed is METTL3; the disease is cancer.